Bone Biologics Corp logo

Bone Biologics Corp

$ 1.12 -0.03 (-2.61%) 10:08 PM EST
P/E:
At Loss
P/B:
2.08
Market Cap:
$ 11.59M
Enterprise V:
$ 24.67M
Volume:
24.73K
Avg Vol (2M):
92.87K
Volume:
24.73K
Market Cap $:
11.59M
PE Ratio:
At Loss
Avg Vol (2-Month):
92.87K
Enterprise Value $:
24.67M
PB Ratio:
2.08
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.99
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 49.7
3-Year EPS without NRI Growth Rate 45.8
3-Year FCF Growth Rate 49
Name Current Vs Industry Vs History
5-Day RSI 38.3
9-Day RSI 39.6
14-Day RSI 40.99
6-1 Month Momentum % -52.65
12-1 Month Momentum % -92.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 79.7
Quick Ratio 79.7
Cash Ratio 76.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.7
Name Current Vs Industry Vs History
ROA % -49.91
ROIC % -28.23
ROC (Joel Greenblatt) % -849.3

Financials (Next Earnings Date:2022-11-15 Est.)

BBLG's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BBLG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.307
Beta 1.19
Volatility % 122.74
14-Day RSI 40.99
14-Day ATR ($) 0.157869
20-Day SMA ($) 1.225
12-1 Month Momentum % -92.85
52-Week Range ($) 1.05 - 18.75025
Shares Outstanding (Mil) 10.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bone Biologics Corp Filings

Document Form Filing Date
No Filing Data

Bone Biologics Corp Analysis

Share your research

Headlines

See More
No news.